Ralf Schmid
Chief Scientific Officer CureSHANK
Seminars
Wednesday 25th March 2026
Evaluating the Right Modalities to Deliver Gene Therapy at Scale in Common Diseases
12:40 pm
- Comparing gene therapy to small molecules and biologics in terms of tractability and therapeutic reach
- Investigating whether advanced modalities like AAV, mRNA, or LNPs can meet the demands of high-prevalence diseases
- Delving into use cases to understand where gene therapy may offer unique value or face limitations
Tuesday 24th March 2026
Evaluating the Right Modalities to Deliver Gene Therapy at Scale in Common Diseases
11:30 am
- Comparing gene therapy to small molecules and biologics in terms of tractability and therapeutic reach
- Investigating whether advanced modalities like AAV, mRNA, or LNPs can meet the demands of high-prevalence diseases
- Delving into use cases to understand where gene therapy may offer unique value or face limitations
